bone graft (OssDsign Inc)
Structured Review
Bone Graft, supplied by OssDsign Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone/bone+grafts/nct05329129-2-41-41
Average 90 stars, based on 1 article reviews
Images
Related Articles
Control:Article Title: PROSPECTIVE OBSERVATIONAL SPINE FUSION REGISTRY FOR OssDsign® BONE GRAFT SUBSTITUTES IN REAL WORLD CLINICAL PRACTICE Article Snippet: The outcomes of patients undergoing spine fusion with Article Title: Use of ceramic synthetic allografts in spine surgery: a narrative review with early basic science and clinic data of novel nanosynthetic bone graft Article Snippet: One such Article Title: "Evidence of Rapid Fusion in a Two Level ACDF Patient Using OssDsign Catalyst® Bone Graft Substitute" Article Snippet: A new Article Title: The current state of cranioplasty in Europe – Results from a European Cranioplasty Survey. Article Snippet: Interestingly, 21 centers (37%) reported preferring mineralic (calcium phosphate) or compound materials, such as composite bioactive glass implant (e.g., GLACETM, Skulle Inc. Finland) or Article Title: PROSPECTIVE OBSERVATIONAL SPINE FUSION REGISTRY FOR OssDsign® BONE GRAFT SUBSTITUTES IN REAL WORLD CLINICAL PRACTICE Article Snippet: The length of study duration and number to be recruited is open-ended but initially a target of 300 subjects will be recruited and followed up for a period of 24 months ± 90 days after their Expressing:Article Title: PROSPECTIVE OBSERVATIONAL SPINE FUSION REGISTRY FOR OssDsign® BONE GRAFT SUBSTITUTES IN REAL WORLD CLINICAL PRACTICE Article Snippet: The outcomes of patients undergoing spine fusion with Article Title: Use of ceramic synthetic allografts in spine surgery: a narrative review with early basic science and clinic data of novel nanosynthetic bone graft Article Snippet: One such Article Title: "Evidence of Rapid Fusion in a Two Level ACDF Patient Using OssDsign Catalyst® Bone Graft Substitute" Article Snippet: A new Article Title: The current state of cranioplasty in Europe – Results from a European Cranioplasty Survey. Article Snippet: Interestingly, 21 centers (37%) reported preferring mineralic (calcium phosphate) or compound materials, such as composite bioactive glass implant (e.g., GLACETM, Skulle Inc. Finland) or Article Title: PROSPECTIVE OBSERVATIONAL SPINE FUSION REGISTRY FOR OssDsign® BONE GRAFT SUBSTITUTES IN REAL WORLD CLINICAL PRACTICE Article Snippet: The length of study duration and number to be recruited is open-ended but initially a target of 300 subjects will be recruited and followed up for a period of 24 months ± 90 days after their Selection:Article Title: PROSPECTIVE OBSERVATIONAL SPINE FUSION REGISTRY FOR OssDsign® BONE GRAFT SUBSTITUTES IN REAL WORLD CLINICAL PRACTICE Article Snippet: The outcomes of patients undergoing spine fusion with Article Title: Use of ceramic synthetic allografts in spine surgery: a narrative review with early basic science and clinic data of novel nanosynthetic bone graft Article Snippet: One such Article Title: "Evidence of Rapid Fusion in a Two Level ACDF Patient Using OssDsign Catalyst® Bone Graft Substitute" Article Snippet: A new Article Title: The current state of cranioplasty in Europe – Results from a European Cranioplasty Survey. Article Snippet: Interestingly, 21 centers (37%) reported preferring mineralic (calcium phosphate) or compound materials, such as composite bioactive glass implant (e.g., GLACETM, Skulle Inc. Finland) or Article Title: PROSPECTIVE OBSERVATIONAL SPINE FUSION REGISTRY FOR OssDsign® BONE GRAFT SUBSTITUTES IN REAL WORLD CLINICAL PRACTICE Article Snippet: The length of study duration and number to be recruited is open-ended but initially a target of 300 subjects will be recruited and followed up for a period of 24 months ± 90 days after their |

